Prescription Drug Patents: Balancing Innovation, Access and Affordability

Time & Location

1:30 - 2:45 PM ET

Market exclusivity promotes innovation in research and development of prescription drugs, but manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market.

During this webinar, panelists explored the relationship between patents, prices, and patient access, including:

  • The importance of developing novel therapies to treat debilitating and costly diseases
  • Challenges for patients and the health care system due to the high costs of prescription drugs
  • Opportunities for biosimilar and generic drugs to bring down drug costs through competition

This webinar is a project of the Alliance for Health Policy and NIHCM Foundation, in collaboration with the Association of Health Care Journalists.


Priti Krishtel, JD


Genia Long, MPP

Analysis Group

Ed Silverman, MA



More Related Content